Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant rates » significant facies (Expand Search), significant risks (Expand Search), significant rise (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant rates » significant facies (Expand Search), significant risks (Expand Search), significant rise (Expand Search)
-
2161
-
2162
Topographic maps of difference in theta functional connectivity between breathing conditions.
Published 2025Subjects: -
2163
-
2164
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
-
2165
-
2166
-
2167
-
2168
-
2169
-
2170
-
2171
-
2172
-
2173
-
2174
Correlation between immune function indicators and Lymphocyte subsets in pSS patients.
Published 2025Subjects: -
2175
-
2176
Demographics and clinical features of healthy controls and primary Sjögren’s Syndrome patients.
Published 2025Subjects: -
2177
Anonymized clinical datasets (patient demographics, medical imaging, and laboratory test records).
Published 2025Subjects: -
2178
Correlation between biochemical indicators and Lymphocyte subsets in pSS patients.
Published 2025Subjects: -
2179
Correlation between immune function indicators and Lymphocyte subsets in pSS patients.
Published 2025Subjects: -
2180